Giuliano La Fratta
Director Financiero/CFO en AETERNA ZENTARIS INC. .
Fortuna: - $ al 31/05/2024
Perfil
Giuliano La Fratta is currently the Chief Financial Officer & Senior Vice President at Æterna Zentaris, Inc. Prior to this, he was the Vice President-Finance at CellCarta Biosciences, Inc. He obtained his undergraduate degree from Concordia University.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
AETERNA ZENTARIS INC.
-.--% | 03/05/2024 | 0 ( -.--% ) | - $ | 31/05/2024 |
Cargos activos de Giuliano La Fratta
| Empresas | Cargo | Inicio |
|---|---|---|
| AETERNA ZENTARIS INC. | Director Financiero/CFO | 24/01/2022 |
Antiguos cargos conocidos de Giuliano La Fratta.
| Empresas | Cargo | Fin |
|---|---|---|
CellCarta Biosciences, Inc.
 CellCarta Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services CellCarta Biosciences, Inc. develops proteomics and immune monitoring services. The firm offers integrated platforms in proteomics and immune monitoring services to the pharmaceutical and biotechnology industry. Its services include biomarker discovery, cell engine software, cellular enumeration, clinical laboratory services, functional profiling, host cell proteins detection, phenotyping characterization and receptor occupancy. The company was founded by Martin LeBlanc in 2000 and is headquartered in Montréal, Canada. | Corporate Officer/Principal | - |
Formación de Giuliano La Fratta.
| Concordia University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| AETERNA ZENTARIS INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
CellCarta Biosciences, Inc.
CellCarta Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services CellCarta Biosciences, Inc. develops proteomics and immune monitoring services. The firm offers integrated platforms in proteomics and immune monitoring services to the pharmaceutical and biotechnology industry. Its services include biomarker discovery, cell engine software, cellular enumeration, clinical laboratory services, functional profiling, host cell proteins detection, phenotyping characterization and receptor occupancy. The company was founded by Martin LeBlanc in 2000 and is headquartered in Montréal, Canada. | Commercial Services |
- Bolsa de valores
- Insiders
- Giuliano La Fratta
